Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Can you specify keytruda's initial fda authorization date?

See the DrugPatentWatch profile for keytruda

Keytruda (pembrolizumab) received its initial FDA approval on March 4, 2014, for unresectable or metastatic melanoma.



Other Questions About Keytruda :

How does one start the keytruda application process? Is keytruda coverage subject to prior approval? Keytruda launch date? Which cancer type did keytruda first gain fda approval in? When is keytruda going off patent? Can you name the year keytruda was first authorized by fda? What was keytruda s primary cancer target at launch?